ReviewThe British journal of radiology2026
Characterizing chronic obstructive pulmonary disease using quantitative MRI biomarkers.
Review in The British journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disease that occurs due to structural changes to the parenchyma, airways and pulmonary vasculature, and consequent functional impairments to ventilation and perfusion. Although computed tomography (CT) imaging is the standard for assessing structural lung changes in COPD, it requires ionizing radiation and is unable to provide functional information without contrast agents. Conversely, there have been numerous developments for MRI of the lungs in the last several decades, allowing for the quantification of structural and functional abnormalities without ionizing radiation. Various quantitative MR (qMR) imaging biomarkers have been developed that describe parenchymal and airway structure as well as ventilation and perfusion within the lungs. These qMR imaging biomarkers have been investigated in individuals with COPD, reporting both cross-sectional and longitudinal associations with important outcomes. Therefore, the aim of this article is to briefly review some commonly used MRI techniques that have been investigated for lung imaging and discuss commonly implemented qMR imaging biomarkers and their application in COPD. Additionally, this review will focus on gaps in the literature that should be addressed to allow for future widespread implementation of qMR imaging biomarkers in COPD-related research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.